CFO of Acorda Therapeutics Inc. (ACOR, Financial) David Lawrence sells 10,905 shares of ACOR on 12/01/2010 at an average price of $26.54 a share.
Acorda Therapeutics Inc. has a market cap of $1.02 billion; its shares were traded at around $26.19 with and P/S ratio of 18.6.
ACOR is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors.
Acorda Therapeutics Inc. has a market cap of $1.02 billion; its shares were traded at around $26.19 with and P/S ratio of 18.6.
ACOR is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors.
CEO Recent Trades:
- Sell: President and CEO Ron Cohen sold 55,000 shares of ACOR stock on 08/05/2010 at the average price of 35.93. Ron Cohen owns at least 286,551 shares after this. The price of the stock has decreased by 27.11% since.
Directors and Officers Recent Trades:
- Sell: Director Lorin Randall sold 5,000 shares of ACOR stock on 08/11/2010 at the average price of 33.52. The price of the stock has decreased by 21.87% since.
- Sell: Director Sandra Phd Panem sold 15,000 shares of ACOR stock on 08/09/2010 at the average price of 35.02. Sandra Phd Panem owns at least 130,685 shares after this. The price of the stock has decreased by 25.21% since.
- Sell: Director Sandra Phd Panem sold 200,000 shares of ACOR stock on 08/06/2010 at the average price of 35.91. Sandra Phd Panem owns at least 145,685 shares after this. The price of the stock has decreased by 27.07% since.
- Sell: Director Steven M Rauscher sold 30,000 shares of ACOR stock on 08/05/2010 at the average price of 36.21. The price of the stock has decreased by 27.67% since.
- Sell: Director Sandra Phd Panem sold 8,397 shares of ACOR stock on 06/14/2010 at the average price of 34. Sandra Phd Panem owns at least 345,685 shares after this. The price of the stock has decreased by 22.97% since.
